Pfizer's Ruxience biosimilar supplement approved; breast cancer trials post resultsSep 30Weekly roundup, 8 itemsatirmociclibberobenatideUpdated
CIBINQO label updated by FDA; Pfizer's rimegepant China trial and pipeline items still activeSep 3Weekly roundup, 7 itemsabrocitinibberobenatide
Pfizer registers Phase 3 trials in alopecia areata and chronic migraine; two Phase 1 studies openJul 29Weekly roundup, 5 itemsBioNTech SEPF-08642534